• Philip T. LoVerdeEmail author
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 1154)


Schistosomiasis is a major cause of morbidity in the world; it is second only to malaria as a major infectious disease. Globally, it is estimated that the disease affects over 250 million people in 78 countries of the world and is responsible for some 280,000 deaths each year. The three major schistosomes infecting humans are Schistosoma mansoni, S. japonicum, and S. haematobium. This chapter covers a wide range of aspects of schistosomiasis, including basic biology of the parasites, epidemiology, immunopathology, treatment, control, vaccines, and genomics/proteomics. In this chapter, the reader will understand the significant toll this disease takes in terms of mortality and morbidity. A description of the various life stages of schistosomes is presented, which will be informative for both those unfamiliar with the disease and experienced scientists. Clinical and public health aspects are addressed that cover acute and chronic disease, diagnosis, current treatment regimens and alternative drugs, and schistosomiasis control programs. A brief overview of genomics and proteomics is included that details recent advances in the field that will help scientists investigate the molecular biology of schistosomes. The reader will take away an appreciation for general aspects of schistosomiasis and research advances.


Schistosomiasis Trematode Cercaria Snail Granuloma Intestinal Urogenital Male–female interplay Praziquantel 



The author acknowledges support from NIH-NIAID (R01 AI115691-01, 1R01AI123434-01) and the Bill and Melinda Gates Foundation (OPP1172792). Electron micrographs (adult worms and cercariae) were provided by Drs. W.O. Granath and Jim Driver at the University of Montana Electron Microscopy Facility ( which is supported, in part, by grant P20GM103474 from the National Institute of General Medical Sciences of the National Institutes of Health. We acknowledge Dr. Allen Cheever for our use of some of his pathology images throughout the manuscript and Dr. Tom Wynn for providing the drawing of Fig. 3.7.


  1. Abdulla M-H, Ruelas DS, Wolff B, Snedecor J, Lim K-C, Xu F, Renslo AR, Williams J, McKerrow JH, Caffrey CR (2009) Drug discovery for schistosomiasis: hit and lead compounds identified in a library of known drugs by medium-throughput phenotypic screening. PLoS Negl Trop Dis 3:e478. Scholar
  2. Anderson TJC, LoVerde PT, Le Clec’h W, Chevalier F (2018) Genetic crosses and linkage mapping in schistosome parasites. Trends Parasitol 34:982–996. Scholar
  3. Bais S, Greenberg RM (2018) TRP channels as potential targets for antischistosomals. Int J Parasitol Drugs Drug Resist 8:511–517. Scholar
  4. Barbosa FS, Coelho MV (1955) Comportamento das formas larvias de Schistosoma mansoni em Australorbis glabratus (Mollusca Planorbidae), sujeitos a estivacao. Publicacoes Avulsas do Instituto Aggeu Magalhaes 4:51–60Google Scholar
  5. Berriman M, Haas BJ, LoVerde PT, Wilson RA, Dillon GP, Cerqueira GC, Mashiyama ST, Al-Lazikani B, Andrade LF, Ashton PD, Aslett MA, Bartholomeu DC, Blandin G, Caffrey CR, Coghlan A, Coulson R, Day TA, Delcher A, DeMarco R, Djikeng A, Eyre T, Gamble JA, Ghedin E, Gu Y, Hertz-Fowler C, Hirai H, Hirai Y, Houston R, Ivens A, Johnston DA, Lacerda D, Macedo CD, McVeigh P, Ning Z, Oliveira G, Overington JP, Parkhill J, Pertea M, Pierce RJ, Protasio AV, Quail MA, Rajandream MA, Rogers J, Sajid M, Salzberg SL, Stanke M, Tivey AR, White O, Williams DL, Wortman J, Wu W, Zamanian M, Zerlotini A, Fraser-Liggett CM, Barrell BG, El-Sayed NM (2009) The genome of the blood fluke Schistosoma mansoni. Nature 16:352–358CrossRefGoogle Scholar
  6. Bethony J, Williams JT, Blangero J, Kloos H, Gazzinelli A, Soares-Filho B, Coelho L, Alves-Fraga L, Williams-Blangero S, LoVerde PT, Correa-Oliveira R (2002) Additive host genetic factors influence fecal egg excretion rates during Schistosoma mansoni infection in a rural area in Brazil. Am J Trop Med Hyg 67:336–343PubMedCrossRefPubMedCentralGoogle Scholar
  7. Black CL, Mwinzi PNM, Muok EMO, Abudho B, Fitzsimmons CM, Dunne DW, Karanja DMS, Secor WE, Colley DG (2010) Influence of exposure history on the immunology and development of resistance to human schistosomiasis mansoni. PLoS Negl Trop Dis 4:e637PubMedPubMedCentralCrossRefGoogle Scholar
  8. Borlase A, Webster JP, Rudge JW (2017) Opportunities and challenges for modelling epidemiological and evolutionary dynamics in a multihost, multiparasite system: zoonotic hybrid schistosomiasis in West Africa. Evol Appl 11:501–515PubMedPubMedCentralCrossRefGoogle Scholar
  9. Caffrey CR (2007) Chemotherapy of schistosomiasis: present and future. Curr Opin Chem Biol 11:433–439PubMedCrossRefPubMedCentralGoogle Scholar
  10. Caldas IR, Campi-Azevedo AC, Oliveira LF, Silveira AM, Oliveira RC, Gazzinelli G (2008) Human schistosomiasis mansoni: immune responses during acute and chronic phases of the infection. Acta Trop 108:109–117PubMedCrossRefPubMedCentralGoogle Scholar
  11. Carlton EJ, Hsiang M, Zhang Y, Johnson S, Hubbard A, Spear RC (2010) The impact of Schistosoma japonicum infection and treatment on ultrasound-detectable morbidity: a five-year cohort study in Southwest China. PLoS Negl Trop Dis 4:e685PubMedPubMedCentralCrossRefGoogle Scholar
  12. Catalano S, Sène M, Diouf ND, Fall CB, Borlase A, Léger E, Bâ K, Webster JP (2018) Rodents as natural hosts of zoonotic schistosoma species and hybrids: an epidemiological and evolutionary perspective from West Africa. J Infect Dis 218:429–433PubMedCrossRefPubMedCentralGoogle Scholar
  13. Cheever AW, Andrade ZA (1967) Pathological lesions associated with Schistosoma mansoni infection in man. Trans R Soc Trop Med Hyg 61:626–639PubMedCrossRefPubMedCentralGoogle Scholar
  14. Cheever AW, Kamel IA, Elwi AM, Mosimann JE, Danner R (1977) Schistosoma mansoni and S. haematobium infections in Egypt. II. Quantitative parasitological findings at necropsy. Am J Trop Med Hyg 26:702–716PubMedCrossRefPubMedCentralGoogle Scholar
  15. Cioli D, Botros SS, Wheatcroft-Francklow K, Mbaye A, Southgate V, Tchuem Tchuenté LA, Pica-Mattoccia L, Troiani AR, El-Din SH, Sabra AN, Albin J, Engels D, Doenhoff MJ (2004) Determination of ED50 values for praziquantel in praziquantel-resistant and -susceptible Schistosoma mansoni isolates. Int J Parasitol 34:979–987PubMedCrossRefPubMedCentralGoogle Scholar
  16. Cioli D, Pica-Mattoccia L, Basso A, Guidi A (2014) Schistosomiasis control: praziquantel forever? Mol Biochem Parasitol 195:23–29PubMedCrossRefPubMedCentralGoogle Scholar
  17. Cogswell AA, Kommer VP, Williams DL (2012) Transcriptional analysis of a unique set of genes involved in Schistosoma mansoni female reproductive biology. PLoS Negl Trop Dis 6:e1907PubMedPubMedCentralCrossRefGoogle Scholar
  18. Collins JJ III, King RS, Cogswell A, Williams DL, Newmark PA (2011) An atlas for Schistosoma mansoni organs and life-cycle stages using cell type-specific markers and confocal microscopy. PLoS Negl Trop Dis 5:e1009. Scholar
  19. Corstjens PL, De Dood CJ, Kornelis D, Fat EM, Wilson RA, Kariuki TM, Nyakundi RK, Loverde PT, Abrams WR, Tanke HJ, Van Lieshout L, Deelder AM, Van Dam GJ (2014) Tools for diagnosis, monitoring and screening of Schistosoma infections utilizing lateral-flow based assays and upconverting phosphor labels. Parasitology 141:1841–1855PubMedPubMedCentralCrossRefGoogle Scholar
  20. Coulson PS (1997) The radiation-attenuated vaccine against schistosomes in animal models: paradigm for a human vaccine? Adv Parasitol 39:271–336PubMedCrossRefPubMedCentralGoogle Scholar
  21. Couto FF, Coelho PM, Araújo N, Kusel JR, Katz N, Jannotti-Passos LK, Mattos AC (2011) Schistosoma mansoni: a method for inducing resistance to praziquantel using infected Biomphalaria glabrata snails. Mem Inst Oswaldo Cruz 106:153–157PubMedCrossRefPubMedCentralGoogle Scholar
  22. Criscione CD, Valentim CLL, Hirai H, LoVerde PT, Anderson TJC (2009) Genomic linkage map of the human blood fluke Schistosoma mansoni. Genome Biol 10:R71PubMedPubMedCentralCrossRefGoogle Scholar
  23. Doenhoff MJ, Cioli D, Utzinger J (2008) Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Curr Opin Infect Dis 21:659–667PubMedCrossRefPubMedCentralGoogle Scholar
  24. Doenhoff MJ, Hagan P, Cioli D, Southgate V, Pica-Mattoccia L, Botros S, Coles G, Tchuem Tchuenté LA, Mbaye A, Engels D (2009) Praziquantel: its use in control of schistosomiasis in sub-Saharan Africa and current research needs. Parasitology 136:1825–1835PubMedCrossRefPubMedCentralGoogle Scholar
  25. Dorsey CH, Cousin CE, Lewis FA, Stirewalt MA (2002) Ultrastructure of the Schistosoma mansoni cercaria. Micron 33:279–323PubMedCrossRefPubMedCentralGoogle Scholar
  26. Fallon PG, Doenhoff MJ (1994) Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific. Am J Trop Med Hyg 51:83–88PubMedCrossRefPubMedCentralGoogle Scholar
  27. Georgi JR (1982) Schistosoma mansoni: quantification of skin penetration and early migration by differential external radioassay and autoradiography. Parasitology 84:263–281PubMedCrossRefPubMedCentralGoogle Scholar
  28. Georgi JR, Wade SE, Dean DA (1987) Schistosoma mansoni: mechanism of attrition and routes of migration from lungs to hepatic portal system in the laboratory mouse. J Parasitol 73:706–711PubMedCrossRefPubMedCentralGoogle Scholar
  29. Gryseels B (1994) Human resistance to Schistosoma infections: age or experience? Parasitol Today 10:380–384PubMedCrossRefPubMedCentralGoogle Scholar
  30. Guidi A, Andolina C, Makame Ame S, Albonico M, Cioli D, Juma-Haji H (2010) Praziquantel efficacy and long-term appraisal of schistosomiasis control in Pemba Island. Trop Med Int Health 15:614–618PubMedPubMedCentralGoogle Scholar
  31. Holtfreter MC, Moné H, Müller-Stöver I, Mouhadi G, Ritcher J (2014) Schistosoma haematobium infections acquired in Corsica, France. August 2013. Euro Surveill 19:20821PubMedCrossRefPubMedCentralGoogle Scholar
  32. Hotez P (ed) (2008) Forgotten people, forgotten diseases: the neglected tropical diseases and their impact on global health and development. ASM, Washington, DCGoogle Scholar
  33. Hotez PJ, Kamath A (2009) Neglected tropical diseases in sub-Saharan Africa: a review of their prevalence, distribution, and disease burden. PLoS Negl Trop Dis 3:e412PubMedPubMedCentralCrossRefGoogle Scholar
  34. Huang HH, Rigouin C, Williams DL (2012) The redox biology of schistosome parasites and applications for drug development. Curr Pharm Des 8:3595–3611Google Scholar
  35. IARC (2012) A review of human carcinogens: biological agents. Vol. B. International Agency for Research on Cancer. World Health Organization, GenevaGoogle Scholar
  36. IFPMA (2017) Merck Praziquantel Donation Program. Accessed 16 Jan 2018
  37. Ingram JR, Rafi SB, Eroy-Reveles AA, Ray M, Lambeth L, Hsieh I, Ruelas D, Lim KC, Sakanari J, Craik CS, Jacobson MP, McKerrow JH (2012) Investigation of the proteolytic functions of an expanded cercarial elastase gene family in Schistosoma mansoni. PLoS Negl Trop Dis 6:e1589PubMedPubMedCentralCrossRefGoogle Scholar
  38. Ismail M, Botros S, Metwally A, William S, Farghally A, Tao LF, Day TA, Bennett JL (1999) Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers. Am J Trop Med Hyg 60:932–935PubMedCrossRefPubMedCentralGoogle Scholar
  39. Jones MK, Bong SH, Green KM, Holmes P, Duke M, Loukas A, McManus DP (2008) Correlative and dynamic imaging of the hatching biology of Schistosoma japonicum from eggs prepared by high pressure freezing. PLoS Negl Trop Dis 2:e334PubMedPubMedCentralCrossRefGoogle Scholar
  40. Jordan PJ (1985) Schistosomiasis: the St. Lucia project. Cambridge University Press, CambridgeGoogle Scholar
  41. King CH, Dickman K, Tisch DJ (2005) Reassessment of the cost of chronic helminthic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 365:1561–1569PubMedCrossRefPubMedCentralGoogle Scholar
  42. LoVerde PT (1975) Scanning electron microscope observations on the miracidium of Schistosoma. Int J Parasitol 5:95–97PubMedCrossRefPubMedCentralGoogle Scholar
  43. LoVerde PT (1976) Scanning electron microscopy of the ova of Schistosoma haematobium and Schistosoma mansoni. Egypt J Bilharz 3:69–72PubMedPubMedCentralGoogle Scholar
  44. LoVerde PT, Carvalho-Querioz C, Cook R (2004a) Vaccination with antioxidant enzymes confers protective immunity against challenge infection with Schistosoma mansoni. Mem Inst Oswaldo Cruz 99:37–43PubMedCrossRefPubMedCentralGoogle Scholar
  45. LoVerde PT, Niles EG, Osman A, Wu W (2004b) Schistosoma mansoni male–female interactions. Can J Zool 82:357–374CrossRefGoogle Scholar
  46. LoVerde PT, Andrade LF, Oliveira G (2009) Signal Transduction Regulates Schistosome Reproductive Biology. Curr Opin Microbiol, 12:422–428PubMedPubMedCentralCrossRefGoogle Scholar
  47. Markel SF, LoVerde PT, Britt EM (1978) Prolonged latent schistosomiasis. JAMA 240:1746–1747PubMedCrossRefPubMedCentralGoogle Scholar
  48. Mbabazi PS, Andan O, Fitzgerald DW, Chitsulo L, Engels D, Downs JA (2011) Examining the relationship between urogenital schistosomiasis and HIV infection. PLoS Negl Trop Dis 5:e1396PubMedPubMedCentralCrossRefGoogle Scholar
  49. Mbow M, Larkin BM, Meurs L, Wammes LJ, de Jong SE, Labuda LA, Camara M, Smits HH, Polman K, Dieye TN, Mboup S, Stadecker MJ, Yazdanbakhsh M (2013) T-helper 17 cells are associated with pathology in human schistosomiasis. J Infect Dis 207:186–195PubMedCrossRefPubMedCentralGoogle Scholar
  50. Melman SD, Steinauer ML, Cunningham C, Kubatko LS, Mwangi IN, Wynn NB, Mutuku MW, Karanja DM, Colley DG, Black CL, Secor WE, Mkoji GM, Loker ES (2009) Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni. PLoS Negl Trop Dis 3:e504PubMedPubMedCentralCrossRefGoogle Scholar
  51. Merrifield M, Hotez PJ, Beaumier CM, Gillespie P, Strych U, Hayward T, Bottazzi ME (2016) Advancing a vaccine to prevent human schistosomiasis. Vaccine 34:2988–2991PubMedCrossRefPubMedCentralGoogle Scholar
  52. Michelson MK, Azziz FA, Gamil FM, Wahid AA, Richards FO, Juranek DD, Habib MA, Spencer HC (1993) Recent trends in the prevalence and distribution of schistosomiasis in the Nile delta region. Am J Trop Med Hyg 49:76–87PubMedCrossRefPubMedCentralGoogle Scholar
  53. Mulvenna J, Moertel L, Jones MK, Nawaratna S, Lovas EM, Gobert GN, Colgrave M, Jones A, Loukas A, McManus DP (2010) Exposed proteins of the Schistosoma japonicum tegument. Int J Parasitol 40:543–554PubMedCrossRefPubMedCentralGoogle Scholar
  54. Nahum LA, Mourão MM, Oliveira G (2012) New frontiers in Schistosoma genomics and transcriptomics. J Parasitol Res 2012:849132PubMedPubMedCentralCrossRefGoogle Scholar
  55. Newton WL (1953) The inheritance of susceptibility to infection with Schistosoma mansoni in Australorbis glabratus. Exp Parasitol 2:242–257CrossRefGoogle Scholar
  56. Pan SC (1980) The fine structure of the miracidium of Schistosoma mansoni. J Invertebr Pathol 36:307–372PubMedCrossRefPubMedCentralGoogle Scholar
  57. Pearce EJ, MacDonald AS (2002) The immunobiology of schistosomiasis. Nat Rev Immunol 2:499–511PubMedCrossRefPubMedCentralGoogle Scholar
  58. Richards CS (1975) Genetic studies of pathologic conditions and susceptibility to infection in Biomphalaria glabrata. Ann N Y Acad Sci 266:394–410PubMedCrossRefPubMedCentralGoogle Scholar
  59. Richards CS, Shade PC (1987) The genetic variation of compatibility in Biomphalaria glabrata and Schistosoma mansoni. J Parasitol 73:1146–1151PubMedCrossRefPubMedCentralGoogle Scholar
  60. Richter J, Hatz C, Campagne G, Bergquist NR, Jenkins JM (2000) Ultrasound in Schistosomiasis: a practical guide to the standard use of ultrasonography for the assessment of schistosomiasis-related morbidity. In: Second International Workshop October 22–26, 1996, Niamey, NigerGoogle Scholar
  61. Rollinson D, Knopp S, Levitz S, Stothard JR, Tchuem Tchuenté LA, Garba A, Mohammed KA, Schur N, Person B, Colley DG, Utzinger J (2012) Time to set the agenda for schistosomiasis elimination. Acta Trop 128:423–440PubMedCrossRefPubMedCentralGoogle Scholar
  62. Ruffer M (1910) Note on the presence of “Bilharzia haematobia” in Egyptian mummies of the twentieth dynasty. Br Med J 1:16PubMedPubMedCentralCrossRefGoogle Scholar
  63. Rugel A, Tarpley R, Lopez A, Menard T, Guzman MA, Taylor AB, Cao X, Kovalskyy D, Chevalier FD, Anderson TJC, Hart PJ, LoVerde PT, McHardy SF (2018) Design, synthesis, and characterization of novel small molecules as broad range anti-schistosomal agents. ACS Med Chem Lett 9:967–973PubMedCrossRefPubMedCentralGoogle Scholar
  64. Sady H, al-Mekhlafi H, Ngui R, Atroosh W, al-Delaimy A, Nasr N, Dawaki S, Abdulsalam A, Ithoi I, Lim Y, Chua K, Surin J (2015) Detection of Schistosoma mansoni and Schistosoma haematobium by real-time PCR with high resolution melting analysis. Int J Mol Sci 16:16085–16103PubMedPubMedCentralCrossRefGoogle Scholar
  65. Salvador-Recatalà V, Greenberg RM (2012) Calcium channels of schistosomes: unresolved questions and unexpected answers. Wiley Interdiscip Rev Membr Transp Signal 1:85–93PubMedPubMedCentralCrossRefGoogle Scholar
  66. Schistosoma japonicum Genome Sequencing and Functional Analysis Consortium (2009) The Schistosoma japonicum genome reveals features of host-parasite interplay. Nature 16:345–351CrossRefGoogle Scholar
  67. Shane HL, Verani JR, Abudho B, Montgomery SP, Blackstock AJ, Mwinzi PN, Butler SE, Karanja DM, Secor WE (2011) Evaluation of urine CCA assays for detection of Schistosoma mansoni infection in Western Kenya. PLoS Negl Trop Dis 5:e951PubMedPubMedCentralCrossRefGoogle Scholar
  68. Shen Y, King CH, Binder S, Zhang F, Whalen CC, Secor WE, Montgomery SP, Mwinzi PN, Olsen A, Magnussen P, Kinung’hi S, Phillips AE, Nalá R, Ferro J, Aurelio HO, Fleming F, Garba A, Hamidou A, Fenwick A, Campbell CH Jr, Colley DG (2017) Protocol and baseline data for a multi-year cohort study of the effects of different mass drug treatment approaches on functional morbidities from schistosomiasis in four African countries. BMC Infect Dis 17:652PubMedPubMedCentralCrossRefGoogle Scholar
  69. Short RB, Grossman AI (1981) Conventional giemsa and C-banded karyotypes of Schistosoma mansoni and S. rodhaini. J Parasitol 67:661–671PubMedCrossRefPubMedCentralGoogle Scholar
  70. Silva LL, Marcet-Houben M, Nahum LA, Zerlotini A, Gabaldón T, Oliveira G (2012) The Schistosoma mansoni phylome: using evolutionary genomics to gain insights into a parasite’s biology. BMC Genomics 13:617PubMedPubMedCentralCrossRefGoogle Scholar
  71. Simpson AJ, Sher A, McCutchan TF (1982) The genome of Schistosoma mansoni: isolation of DNA, its size, bases and repetitive sequences. Mol Biochem Parasitol 6:125–137PubMedCrossRefPubMedCentralGoogle Scholar
  72. Southgate VR, Tchuem Tchuenté AL, Sène M, De Clercq D, Théron A, Jourdane J, Webster BL, Rollinson D, Gryseels B, Vercruysse J (2001) Studies on the biology of schistosomiasis with emphasis on the Senegal River basin. Mem Inst Oswaldo Cruz 96:S75–S78CrossRefGoogle Scholar
  73. Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J (2006) Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 6:411–425PubMedCrossRefPubMedCentralGoogle Scholar
  74. Stirewalt MA (1956) Penetration of host skin by cercariae of Schistosoma mansoni. I. Observed entry into skin of mouse, hamster, rat, monkey and man. J Parasitol 42:565–580PubMedCrossRefPubMedCentralGoogle Scholar
  75. Stirewalt MA (1966) Skin penetration mechanisms of helminths. In: Soulsby EJL (ed) Biology of parasites. Academic, New York, pp 41–58Google Scholar
  76. Stirewalt MA (1974) Schistosoma mansoni: cercaria to schistosomule. Adv Parasitol 12:115–182PubMedCrossRefPubMedCentralGoogle Scholar
  77. Stirewalt MA, Cousin CE, Dorsey CH (1983) Schistosoma mansoni: stimulus and transformation of cercariae into schistosomules. Exp Parasitol 56:358–368PubMedCrossRefPubMedCentralGoogle Scholar
  78. Taylor AB, Roberts KM, Cao X, Clark NE, Holloway SP, Donati E, Polcaro CM, Pica-Mattoccia L, Tarpley RS, McHardy SF, Cioli D, LoVerde PT, Fitzpatrick PF, Hart PJ (2017) Structural and enzymatic insights into species-specific resistance to schistosome parasite drug therapy. J Biol Chem 292:11154–11164PubMedPubMedCentralCrossRefGoogle Scholar
  79. Tchuem-Tchuenté L-A, Kueté-Fouodo CJ, Kamwa-Ngassam RI, Sumo L, Dongmo Noumedem C, Kenfack CM, Gipwe NF, Nana ED, Stothard JR, Rollinson D (2012) Evaluation of circulating cathodic antigen (CCA) urine-tests for diagnosis of Schistosoma mansoni infection in Cameroon. PLoS Negl Trop Dis 6:e1758PubMedPubMedCentralCrossRefGoogle Scholar
  80. Tebeje BM, Harvie M, You H, Loukas A, McManus DP (2016) Schistosomiasis vaccines: where do we stand? Parasit Vectors 9:528PubMedPubMedCentralCrossRefGoogle Scholar
  81. Valentim CLL, Cioli D, Chevalier FD, Cao X, Taylor AB, Holloway SP, Pica-Mattoccia L, Guidi A, Basso A, Tsai IJ, Berriman M, Carvalho-Queiroz C, Almeida M, Aguilar H, Frantz DE, Hart PJ, LoVerde PT, Anderson TJC (2013) Genetic and molecular basis of drug resistance and species-1 specific drug action in Schistosome parasites. Science 342:1385–1389PubMedPubMedCentralCrossRefGoogle Scholar
  82. Van der Werf MJ, de Vlas SJ, Brooker S, Looman CWN, Nagelkerke NJD, Habbema JDF, Engels D (2003) Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop 86:125–139PubMedCrossRefPubMedCentralGoogle Scholar
  83. Wei DX, Yang WY, Huang SQ, Lu YF, Su TC, Ma JH, Hu WX, Xie NF (1980) Parasitological studies on the ancient corpse of the Western Han dynasty unearthed from tomb no. 188 on Phoenix Hill at Jiangling County. Acta Acad Med Wuhan 3:1–6Google Scholar
  84. Wiegand RE, Mwinzi PNM, Montgomery SP, Chan YL, Omedo KAM, Muchiri G, Ogutu MO, Rawago F, Odiere MR, Karanja DMS, Secor WE (2017) A persistent hotspot of Schistosoma mansoni infection in a five-year randomized trial of praziquantel preventative chemotherapy strategies. J Infect Dis 216:1425–1433PubMedPubMedCentralCrossRefGoogle Scholar
  85. World Health Organization (1985) The control of schistosomiasis. WHO technical reports series 728. WHO, GenevaGoogle Scholar
  86. World Health Organization (2006) Preventive chemotherapy in human helminthiasis. Coordinated use of anthelminthic drugs in control interventions, a manual for health professionals and programme managers. Accessed 7 Mar 2001
  87. World Health Organization (2010) First WHO report on neglected tropical diseases. Accessed 17 Oct 2016
  88. World Health Organization (2013) Schistosomiasis: progress report 2001–2011, strategic plan 2012–2020. Accessed 17 Oct 2016
  89. World Health Organization (2018) Schistosomiasis fact sheet. Accessed 28 Sept 2018
  90. Wynn TA, Thompson RW, Cheever AW, Mentink-Kane MM (2004) Immunopathogenesis of schistosomiasis. Immunol Rev 201:156–167PubMedCrossRefPubMedCentralGoogle Scholar
  91. Young ND, Jex AR, Li B, Liu S, Yang L, Xiong Z, Li Y, Cantacessi C, Hall RS, Xu X, Chen F, Wu X, Zerlotini A, Oliveira G, Hofmann A, Zhang G, Fang X, Kang Y, Campbell BE, Loukas A, Ranganathan S, Rollinson D, Rinaldi G, Brindley PJ, Yang H, Wang J, Wang J, Gasser RB (2012) Whole-genome sequence of Schistosoma haematobium. Nat Genet 44:221–225PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of Biochemistry and Structural BiologyUniversity of Texas HealthSan AntonioUSA
  2. 2.Department of Pathology and Laboratory MedicineUniversity of Texas HealthSan AntonioUSA

Personalised recommendations